← back to search

Jesús Gil

Hammersmith Hospital · GB
Area of research
Physiology · Molecular Biology
Research interest
Research interests include Telomeres, Telomerase, and Senescence, Epigenetics and DNA Methylation, Genomics and Chromatin Dynamics, and Genetics, Aging, and Longevity in Model Organisms.
h-index
72
citations
29,688
works
227
NIH funding
primary concept
Biology
email

Recent publications

Guidelines for minimal information on cellular senescence experimentation in vivo
Cell 2024cited by 262position: middledoi
Inhibition of IL-11 signalling extends mammalian healthspan and lifespan
Nature 2024cited by 203position: middledoi
Detection of senescence using machine learning algorithms based on nuclear features
Nature Communications 2024cited by 72position: lastdoi
Ribosomal S6 kinase 1 regulates inflammaging via the senescence secretome
Nature Aging 2024cited by 24position: middledoi
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus Statement
medRxiv 2024cited by 2position: middledoi
Author Correction: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Nature Cell Biology 2024cited by 1position: lastdoi
Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer
Cancer Cell 2023cited by 224position: middledoi
COPI vesicle formation and N-myristoylation are targetable vulnerabilities of senescent cells
Nature Cell Biology 2023cited by 53position: lastdoi
Ribosomal S6 kinase 1 regulates ‘inflammaging’ via the senescence secretome
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 1position: middledoi
Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression
Circulation 2022cited by 130position: middledoi
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy
JNCI Journal of the National Cancer Institute 2021cited by 330position: middledoi
Spontaneous Cholemia in C57BL/6 Mice Predisposes to Liver Cancer in NASH
Cellular and Molecular Gastroenterology and Hepatology 2021cited by 16position: middledoi
LGG-09. SENOLYTIC AGENT NAVITOCLAX TARGETS VINBLASTINE- AND MAPK INHIBITORS-INDUCED SENESCENT TUMOUR CELLS IN PAEDIATRIC LOW GRADE GLIOMAS
Neuro-Oncology 2021cited by 2position: middledoi
Prostate carcinogenesis: inflammatory storms
Nature reviews. Cancer 2020cited by 238position: middledoi
Cellular Senescence: Defining a Path Forward
Cell 2019cited by 3,048position: middledoi
Cardiac glycosides are broad-spectrum senolytics
Nature Metabolism 2019cited by 350position: lastdoi
PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells
Cancer Cell 2018cited by 245position: lastdoi
Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target
Acta Neuropathologica 2018cited by 210position: middledoi
Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma
Nature Communications 2017cited by 133position: middledoi
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Nature Cell Biology 2015cited by 759position: lastdoi
Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors
Nature Medicine 2015cited by 161position: middledoi
Netrin-1 regulates somatic cell reprogramming and pluripotency maintenance
Nature Communications 2015cited by 50position: middledoi
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer
Oncotarget 2015cited by 25position: middledoi
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Nature Cell Biology 2013cited by 2,200position: lastdoi
Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK4a regulation
The EMBO Journal 2013cited by 37position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Mathias Heikenwälder · German Cancer Research Center7 papers (2015–2024)Suchira Gallage · German Cancer Research Center7 papers (2015–2024) · 7 papers (2015–2024)Gopuraja Dharmalingam · Eli Lilly (United States)6 papers (2013–2024)Juan Pedro Martı́nez-Barberá · University College London5 papers (2015–2024)Nicolás Herranz · Medical Research Council5 papers (2015–2024)Joaquim Pombo · MRC London Institute of Medical Sciences5 papers (2018–2024)Athena Georgilis · Hammersmith Hospital4 papers (2013–2024)Jose Efren Barragan Avila · German Cancer Research Center4 papers (2021–2024)Lars Zender · Deutsche Forschungsgemeinschaft4 papers (2013–2024)Santiago Vernia · Hammersmith Hospital4 papers (2023–2024)Gareth J. Thomas · Cambridge University Hospitals NHS Foundation Trust4 papers (2015–2024) · 3 papers (2023–2024)Sanjay Khadayate · MRC London Institute of Medical Sciences3 papers (2023–2024)Torsten Wüestefeld · Medizinische Hochschule Hannover3 papers (2013–2024)Massimiliano Mellone · University of Southampton3 papers (2015–2024)Ana Banito · German Cancer Research Center3 papers (2013–2024)Sabrina Klotz · University of Tübingen3 papers (2015–2024) · 3 papers (2021–2024)Danijela Heide · German Cancer Research Center3 papers (2018–2024)